Breckenridge Pharmaceutical, Inc launches Pencillamine Capsules, USP
21 April 2022 -

Breckenridge Pharmaceutical, Inc, a US-based subsidiary of Japan-based Towa Pharmaceutical, announced on Wednesday that it has introduced its Pencillamine Capsules, USP (generic for Cuprimine).

Aggrega Pharma, LLC has produced the product.

The company is to market the product on its own label and provide the 250mg strength in bottles of 100. It had earlier received the final approval of the Abbreviated New Drug Application (ANDA) for this product from the United States Food and Drug Administration (FDA).